0 Articles
0 News
0 Properties
0 Page
0 Blog


Stepping Up in the COVID-19 Pandemic

Across the Brazos Valley, companies and organizations are stepping up in a variety of ways as the COVID-19 pandemic affects the community.
If you know of an example of a local company contributing to the fight against the virus and assisting those who are caring for the ill, email sfullhart@brazosvalleyedc.org.


The president of Acme Glass in Downtown Bryan, Mitchell Morehead, says they typically replace car windshields at that location, but when he got a call from a friend in the medical field, they did a slight pivot. Morehead’s friend asked him if he thought he would be able to build intubation boxes.


At Home in BCS is a collaborative effort to maintain a sense of community while being at home during these unique times. Features will include virtual events, details on take-out and delivery options at local restaurants and retail shops, and much more. Experience BCS, the B/CS Chamber of Commerce, the Downtown Bryan Association, the Cities of Bryan and College Station, and the BVEDC are working together on #AtHomeinBCS.


CHI St. Joseph Health and Texas A&M Veterinary Medical Diagnostic Laboratory have partnered to offer increased accessibility to SARS CoV2 (COVID-19) testing for the community through the TVMDL lab at the Texas A&M University campus.


In June, Cognizant announced a partnership with Verily Life Sciences to facilitate increased COVID-19 testing across the country. Cognizant's US Corporation Headquarters are in College Station.


FUJIFILM Diosynth Biotechnologies (FDB) is utilizing its network of leading scientists, engineers and production facilities in both Europe and the USA, including those located in College Station, Texas to manufacture clinical material in short order to support the global efforts to control COVID-19. FDB stands ready to support United States government efforts to respond to the manufacture of a COVID-19 vaccine.
On June 1, FDB was announced as the manufacturing partner with Tonix Pharmaceuticals. Under the agreement, FDB will develop a manufacturing process, manufacture and stock a supply of Tonix's COVID-19 vaccine candidate, TNX-1800, at FDB's College Station site.
On July 27, President Trump announced the federal government has reserved capacity with the Texas A&M University System's Center for Innovation in Advanced Development and Manufacturing for production of a top COVID-19 vaccine candidate. FDB is the subcontractor for the A&M System which will produce the vaccines at its facilities.


G-CON Manufacturing, makers of prefabricated cleanrooms known as PODs, is fielding several requests from drug manufacturers to build cleanrooms for COVID-19 purposes, both for mobile labs and for drug manufacturing. At the same time, the company has been able to keep current clients' projects going. G-CON does not have to on their clients' sites because PODs are built off-site at their Brazos Valley facility. The company is helping big pharma companies keep with their timelines to get drugs out to patients without risking a delay in construction.


The plant-based biologics manufacturing company has been working to create a vaccine for COVID-19 since February. The company announced in mid-March they have filed four patent applications of vaccines.
On August 10, iBio announced preclinical studies of a COVID-19 vaccine candidate showed an ability to generate an immune response to COVID-19.
On August 28, an exclusive worldwide license agreement was announced between iBio and Planet Biotechnology. iBio will develop Planet's COVID-19 therapeutic candidate.


Owner Nathan Barkman says he's received numerous requests to make hand sanitizer, so that's what they're going to start doing. "We had to become experts in hand sanitizer. There's a learning curve, but it's really not that complicated once you have the juice but it's 100 percent Texas grain to glass hand sanitizer," said Barkman.


Dr. Jeffrey Cirillo at the Texas A&M Health Science Center is leading a group of world-renown institutions in a clinical trial that could deliver a COVID-19 treatment in six months. He can do this because he is using an existing vaccine which has been used for decades. Texas A&M is the first U.S. institution in the clinical trial that has federal approval to test humans.
An assistant professor in the School of Public Health is helping local officials monitor the spread of the COVID-19 pandemic in College Station and Brazos County.
In the wake of the novel coronavirus pandemic, Texas A&M University chemist Wenshe Ray Liu and his research team have focused their lab solely on searching for drugs to treat COVID-19.
A team of A&M scientists is working on two COVID-19 vaccine candidates that could be mass produced quickly in modified tobacco plants. The team, led by regents' professor Dr. James Samuel, is testing the vaccine candidates at iBio.



For about a decade, holsters have been owner Justin Sitz’s specialty at Versacarry, but as COVID-19 concerns began to rise, he turned his focus toward face shields for medical professionals.